Hims & Hers director granted 647 RSUs
Payne Christopher D reported acquisition or exercise transactions in this Form 4 filing.
Rhea-AI Filing Summary
Payne Christopher D reported acquisition or exercise transactions in this Form 4 filing.
Hims & Hers Health, Inc. director Christopher D. Payne received a grant of 647 Restricted Stock Units as equity compensation. Each RSU represents a contingent right to receive one share of Class A common stock. The award was issued under the company’s Director Compensation Policy.
The RSUs were granted in lieu of $14,875 in director and committee cash fees for the first quarter of 2026, using a grant price of $22.98. All 647 RSUs will vest in full on the company’s next quarterly vesting date, leaving Payne with 647 RSUs reported as directly owned after this transaction.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 647 shares
Grant/Award
1 txn
Insider
Payne Christopher D
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Unit | 647 | $0.00 | $0.00 |
Holdings After Transaction:
Restricted Stock Unit — 647 contracts (Direct)
Footnotes (2)
- F1. The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.
- F2. The RSUs were issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy, in lieu of the director retainer and committee membership fees for the first quarter of 2026. The number of RSUs granted was calculated by dividing the foregone cash fees of $14,875 by the grant price of $22.98. The RSUs will vest in full on the Company's next quarterly vesting date.
Key Figures
RSUs granted: 647 units
Foregone cash fees: $14,875
Grant price: $22.98 per share
+2 more
5 metrics
RSUs granted
647 units
Restricted Stock Units granted on May 20, 2026
Foregone cash fees
$14,875
Director and committee fees for Q1 2026 converted to RSUs
Grant price
$22.98 per share
Used to calculate RSUs from foregone fees
Underlying shares
647 shares
Class A common stock underlying the RSUs
Holdings after transaction
647 RSUs
Total RSUs reported as directly owned following grant
Key Terms
Restricted Stock Unit, Director Compensation Policy, grant price, Class A Common Stock
4 terms
Restricted Stock Unit financial
"The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU."
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
Director Compensation Policy financial
"The RSUs were issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy, in lieu of the director retainer and committee membership fees..."
grant price financial
"The number of RSUs granted was calculated by dividing the foregone cash fees of $14,875 by the grant price of $22.98."
Class A Common Stock financial
"The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU."
Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.
FAQ
What insider transaction did Hims & Hers Health (HIMS) report for Christopher D. Payne?
Christopher D. Payne received 647 Restricted Stock Units as equity compensation. The RSUs were granted in lieu of director and committee cash fees for the first quarter of 2026 and will vest in full on the company’s next quarterly vesting date.
How many Hims & Hers (HIMS) RSUs did Christopher D. Payne receive and what do they represent?
Payne received 647 Restricted Stock Units from Hims & Hers Health. Each RSU represents a contingent right to receive one share of Class A common stock, meaning he can receive 647 shares if the units fully vest as scheduled.
What cash amount did the Hims & Hers (HIMS) RSU grant replace for Christopher D. Payne?
The RSU grant replaced $14,875 of director and committee cash fees. The company converted those foregone cash fees into 647 Restricted Stock Units using a stated grant price of $22.98 per share for the first quarter of 2026.
How was the number of RSUs for Hims & Hers (HIMS) director Christopher D. Payne calculated?
The 647 RSUs were calculated by dividing $14,875 by $22.98. The filing states that the foregone cash fees of $14,875 were divided by the grant price of $22.98, resulting in a grant of 647 Restricted Stock Units for the director.
When will Christopher D. Payne’s Hims & Hers (HIMS) RSUs vest?
The RSUs will vest in full on the company’s next quarterly vesting date. Once that vesting date occurs, the 647 Restricted Stock Units are scheduled to convert into an equal number of Class A common shares, assuming continued eligibility.
Is the Hims & Hers (HIMS) RSU grant to Christopher D. Payne a market purchase or sale?
The RSU grant is a compensation award, not a market trade. The Form 4 shows a grant coded as an acquisition (A), issued under the Director Compensation Policy in lieu of cash fees, with no open-market buying or selling involved.
AI-generated analysis. How Rhea-AI works. Not financial advice.
